Available IPD datapackage for study 'Phase I/II Open Label Dose Escalation Study of the 17α-Hydroxylase/ C17,20-Lyase Inhibitor, Abiraterone Acetate in Hormone Refractory Prostate Cancer'

Name: Available IPD datapackage for study 'Phase I/II Open Label Dose Escalation Study of the 17α-Hydroxylase/ C17,20-Lyase Inhibitor, Abiraterone Acetate in Hormone Refractory Prostate Cancer'
Creator: Vivli
Published: 2025-10-10 09:02:44
License: 暂无描述

DataCite Commons2025-10-10 更新2026-05-07 收录

下载链接：

https://search.vivli.org/doiLanding/dataPackages/PR00005174.1

下载链接

链接失效反馈

官方服务：

资源简介：

The purpose of this study is to evaluate the safety, pharmacokinetics, pharmacodynamics, and anti‑tumor activities of abiraterone acetate (also referred to as CB7630) in patients with hormone refractory prostate cancer (HRPC).

提供机构：

Vivli

创建时间：

2025-10-10